Chapter 66 On the eve of listing
The working conditions of employees in companies with development prospects and those without development prospects are completely different.

The impact of the environment on individuals is the most important. After Guangjia Technology received 15 billion in external financing, everyone's expectations for it changed from a startup company to a company with a market value of tens of billions. Coupled with the state-owned background and the reputation of the founder, the employees are very optimistic and believe that it is only a matter of time before Guangjia Technology goes public.

China's stock market is different from other countries' stock markets. The difference is not that the money-making effect is poor. The fundamental difference is that other countries' stock markets are a barometer of corporate operating conditions and are intended to help companies survive better.

The Chinese stock market is meant to help companies survive. As long as you can continue to operate and solve employment problems, it doesn't matter if you commit financial fraud, deceive small and medium-sized investors, or maliciously manipulate stock prices. It is nothing more than raising the paddle high and then dropping it gently, because the fundamental purpose of the Chinese stock market is to help companies survive.

The test-takers who will join Guangjia Technology may not be able to summarize this point, but they are very clear that if Guangjia Technology goes public, the options will be cashed in sooner or later.

Therefore, most of the earliest scientific researchers left, and some of the researchers who later joined Guangjia Technology took a pay cut, where pay cut means receiving less salary.

Everyone feels that Guangjia Technology has unlimited prospects and its listing is just around the corner.

The prerequisite for listing is that the company must have products that can be presented, and the products must be able to create value for the company. Listing on the Science and Technology Innovation Board requires operating income to exceed RMB 3000 million for two consecutive years and positive net profit.

"Boss, the data from this clinical trial is consistent with the experimenters' feelings. Just as you speculated, there was a deviation between the area we found and the actual area. After a large number of experiments, the current clinical trial results are almost consistent with the results shown on the experimental monkeys." Song Ming, a PhD who was recruited later, served as Chen Yuanguang's assistant on this project.

A researcher from the Institute of Neuroscience of the Chinese Academy of Sciences. He had a high rank before joining Guangjia Technology, and his name can still be found on Baidu Encyclopedia.

It is estimated that Chen Yuanguang was sent by the relevant departments to participate in the front-line research of human hibernation technology.

Chen Yuanguang didn't mind. He didn't have the capital to keep all the technologies completely confidential. If the relevant departments didn't do the confidentiality work, the news would have leaked out like a sieve.

So after Song Ming fully demonstrated his abilities, Chen Yuanguang quickly entrusted him with an important task and made him the vice president in charge of research and development.

Chen Yuanguang nodded: "It seems that we will be able to enter the second phase of clinical trials soon."

Chen Yuanguang thought for a moment and then said, "I know that many researchers joined Guangjia Technology because they wanted Guangjia Technology to go public. After all, a large part of the salary we give everyone is option incentives.

Previously, the person in charge of the issuance of the Science and Technology Innovation Board at CICC came to talk to me, and they meant that the product could be listed after completing the second phase of clinical trials.”

Song Ming didn't care about these things, but he could not help but hear about them from his colleagues. "Is the second phase enough? Don't they say that there must be operating income and actual profits?

It seems that our main source of income is currently government policy subsidies, which probably cannot meet the listing requirements. "

Chen Yuanguang said: "I thought so before. After CICC introduced it to me in detail, I realized that companies like us can take the fifth path. The estimated market value is not less than 40 billion RMB. If the main business achieves phased results, we can go public.

Companies like those that work on quantum computers are taking this path.

Because we are in the pharmaceutical industry, we can launch our products as soon as we have at least one core product that has started Phase II clinical trials. We can just start, not finish. So once this phase of clinical trials is completed and the next phase is approved, Guangjia Technology can launch its products.”

Before simulating business operations, Chen Yuanguang was not interested in going public at all. He felt that companies only go public when they have no money, and there was no need to go public when the business was doing well. Going public would dilute his shares and he would also face the risk of others raising their hands to compete for control.

Only now did he realize that the stock market, especially the Chinese stock market, is a place where companies can repeatedly obtain large amounts of low-cost liquidity.

You can issue targeted additional shares, pledge your shares, issue bonus shares, issue convertible bonds, etc.

Compared with borrowing money from a bank, the cost of funds in the stock market is even lower.

Therefore, Chen Yuanguang also hopes to list Guangjia Technology as soon as possible. As long as the shares have different voting rights, the control of Guangjia Technology will always be firmly in his hands.

“So that’s how it is. When I was at the Academy of Sciences, I learned about some companies listed on the Science and Technology Innovation Board. I felt that they had no profitability, but they were able to go public.

Those companies have a lot of PhDs and masters, so their salary costs should be very high. Their products have very narrow demand, and some are even pseudo-concepts. They have pushed their market value up to hundreds of billions. I guess this is how they first went public.”

Chen Yuanguang's sharpness allowed him to quickly guess which company it was, but he did not expand on the topic. "Dr. Song, I'll trouble you to complete the Phase I clinical trial, and then start to summarize the experimental data to promote the application for the Phase II clinical trial."

Du Nanping usually makes a living by driving online ride-hailing cars, mainly Didi, and occasionally other platforms. When driving, he likes to curse the unscrupulous platforms for exploiting him too much. In addition to his main job, he is also a drug tester. Unlike drug testers with some specific diseases, he is relatively healthy and has no infectious diseases, heart disease, digestive system diseases, etc. This is a healthy subject.

People work in this industry for the quick money. In two cycles, just by taking medicine and going through checkups, you can get eight or nine thousand or even tens of thousands of dollars. This money comes easily.

Of course, behind the ease lies the risk, but as an experienced drug tester, Du Nanping has joined many groups related to sharing drug testing information. In addition, he has participated in so many drug trials himself, so he has his own judgment on which ones are relatively safe and which ones are risky.

"Shenhai tertiary hospital is recruiting drug testers, 98 people will be included in the group, the screening interval is one day, no tattoo check, the subsidy amount is 9000 yuan for men and 9500 yuan for women. A deposit needs to be paid in advance. If you are interested, please chat privately."

Even if you have to pay a deposit, I won’t go to a top-tier hospital.

"Zhangjiang Hi-Tech Multinational Giant is recruiting drug testers, with 327 participants, who are required to have complications of diabetes and hypertension, and the subsidy amount."

Multinational giants need to have diabetes, not to go.

"Caohejing Startup Company is recruiting drug testers. The number of participants is 500. No gender is limited. Tattoos are not checked. The subsidy amount is 10000 yuan. No deposit is required. There is no disease requirement. In short, it only takes people. If you are willing, please chat privately. First come, first served."

It looks like something is wrong, but why is it so tempting? I should chat with him privately and ask, Du Nanping thought.

(End of this chapter)